<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Ward JM</submitter><funding>Lupus Foundation of America (CFW)</funding><funding>NIAID NIH HHS</funding><funding>National Institutes of Health</funding><funding>NIAMS NIH HHS</funding><funding>NIGMS NIH HHS</funding><pagination>213-9</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5021782</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>9</volume><pubmed_abstract>Previously published studies revealed that variation in expression of the DNA-binding protein ARID3a in B lymphocytes from patients with systemic lupus erythematosus (SLE) correlated with levels of disease activity ("Disease activity in systemic lupus erythematosus correlates with expression of the transcription factor AT-rich-interactive domain 3A" (J.M. Ward, K. Rose, C. Montgomery, I. Adrianto, J.A. James, J.T. Merrill et al., 2014) [1]). The data presented here compare DNA methylation patterns from SLE peripheral blood mononuclear cells obtained from samples with high numbers of ARID3a expressing B cells (ARID3a(H)) versus SLE samples with normal numbers of ARID3a(+) B cells (ARID3a(N)). The methylation data is available at the gene expression omnibus (GEO) repository, "Gene Expression</pubmed_abstract><journal>Data in brief</journal><pubmed_title>Expression and methylation data from SLE patient and healthy control blood samples subdivided with respect to ARID3a levels.</pubmed_title><pmcid>PMC5021782</pmcid><funding_grant_id>P30 GM110766</funding_grant_id><funding_grant_id>U54 GM104938</funding_grant_id><funding_grant_id>GM104938</funding_grant_id><funding_grant_id>AR053483</funding_grant_id><funding_grant_id>R21 AI090343</funding_grant_id><funding_grant_id>R01 AR056360</funding_grant_id><funding_grant_id>U19 AI082714</funding_grant_id><funding_grant_id>P30 GM103510</funding_grant_id><funding_grant_id>GM103510</funding_grant_id><funding_grant_id>R01 AR063124</funding_grant_id><funding_grant_id>T32 AI007633</funding_grant_id><funding_grant_id>R01 AI044215</funding_grant_id><funding_grant_id>AIO90343</funding_grant_id><funding_grant_id>AI082714</funding_grant_id><funding_grant_id>R56 AI118836</funding_grant_id><funding_grant_id>AR063124</funding_grant_id><funding_grant_id>GM110766</funding_grant_id><funding_grant_id>AR056360</funding_grant_id><funding_grant_id>P30 AR053483</funding_grant_id><funding_grant_id>R01 AI118836</funding_grant_id><funding_grant_id>AI101934</funding_grant_id><funding_grant_id>U01 AI101934</funding_grant_id><funding_grant_id>AI044215</funding_grant_id><pubmed_authors>Dozmorov MG</pubmed_authors><pubmed_authors>James JA</pubmed_authors><pubmed_authors>Wiley G</pubmed_authors><pubmed_authors>Ratliff ML</pubmed_authors><pubmed_authors>Guthridge JM</pubmed_authors><pubmed_authors>Webb CF</pubmed_authors><pubmed_authors>Gaffney PM</pubmed_authors><pubmed_authors>Ward JM</pubmed_authors></additional><is_claimable>false</is_claimable><name>Expression and methylation data from SLE patient and healthy control blood samples subdivided with respect to ARID3a levels.</name><description>Previously published studies revealed that variation in expression of the DNA-binding protein ARID3a in B lymphocytes from patients with systemic lupus erythematosus (SLE) correlated with levels of disease activity ("Disease activity in systemic lupus erythematosus correlates with expression of the transcription factor AT-rich-interactive domain 3A" (J.M. Ward, K. Rose, C. Montgomery, I. Adrianto, J.A. James, J.T. Merrill et al., 2014) [1]). The data presented here compare DNA methylation patterns from SLE peripheral blood mononuclear cells obtained from samples with high numbers of ARID3a expressing B cells (ARID3a(H)) versus SLE samples with normal numbers of ARID3a(+) B cells (ARID3a(N)). The methylation data is available at the gene expression omnibus (GEO) repository, "Gene Expression</description><dates><release>2016-01-01T00:00:00Z</release><publication>2016 Dec</publication><modification>2026-05-04T16:19:38.914Z</modification><creation>2019-03-27T02:24:09Z</creation></dates><accession>S-EPMC5021782</accession><cross_references><pubmed>27656675</pubmed><doi>10.1016/j.dib.2016.08.049</doi></cross_references></HashMap>